We are looking for the future of medicine.
Behind OAM Medical is an active investor. We back AI-driven medical applications — diagnostics, longevity, clinical workflow, precision care — with capital, clinical access, and the OM Group behind them.
Operators who built the technology, now deploying capital.
OAM Medical is led by specialists from Philips and GE Healthcare, alongside practising clinicians — and backed by the OM Group of Companies. We have built medical technology, run it in clinical settings, and now invest in the teams advancing it with AI.
Where we are actively writing cheques.
AI diagnostics
Imaging, pathology and signal models that detect earlier and more accurately than a busy clinic can.
Longevity & data platforms
Diagnostics-led longevity, biomarkers, and the software that turns them into clinical protocols.
Clinical workflow AI
Tools that remove friction for clinicians and scale quality of care without scaling cost.
Precision & regenerative
Data-driven precision and regenerative approaches with a credible, defensible evidence base.
Capital is common. Clinical access is not.
We bring more than a cheque: regulatory familiarity in the Kingdom, clinical sites to pilot in, distribution across the GCC, and operators who have shipped medical technology at scale. For the right team, that is the difference between a pilot and a market.
How we think about medicine and AI.
Notes from our investment and clinical teams on where the value is — and where it isn't.